CHAD RAMSEY

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting legislation to improve access and care for ovarian cancer patients including: S 765/HR 1526 Reducing Hereditary Cancer Act S 642 Finn Sawyer Access to Cancer Testing Act Coverage for multi-cancer early diagnosis legislation Johanna's Law Modernization and Reauthorization Act

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting HR 1946 to provide coverage for a multi-cancer screening diagnostic when it is FDA-approved. Supporting S. 1612 and S. 368 to improve telehealth medicine. Supporting HR 4412 to reauthorize Johanna's Law.

Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.

Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.

Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.

Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.

Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.

Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.

Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.

Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.

Supporting increased funding for CDMRP's OCRP in FY2020 Defense appropriations Support for increased funding fro ovarian cancer reserach and surveillance in FY2020 Labor-HHS-Ed appropriations (no bill # yet) Supporting the introduction of Access to Genetic Counselor Services Act Pursuing additional cosponasors and hearing for Cancer Drug Parity Act of 2019 (S.741/H.R.1730) Pursuing support for CLINICAL TREATMENT Act (H.R.913)

Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.

Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.

Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.

Supporting passage of H.R.4560 To amend the Public Health Service Act to reauthorize Johanna's Law, and for other purposes. Supporting passage of H.R.913 the CLINICAL TREATMENT Act.

Supporting increased funding for CDMRP's OCRP in FY2020 Defense appropriations Support for increased funding fro ovarian cancer reserach and surveillance in FY2020 Labor-HHS-Ed appropriations (no bill # yet) Supporting the introduction of Access to Genetic Counselor Services Act Pursuing additional cosponasors and hearing for Cancer Drug Parity Act of 2019 (S.741/H.R.1730) Pursuing support for CLINICAL TREATMENT Act (H.R.913)

Supporting increased funding for CDMRP's OCRP in FY2020 Defense appropriations Support for increased funding fro ovarian cancer reserach and surveillance in FY2020 Labor-HHS-Ed appropriations (no bill # yet) Supporting the introduction of Access to Genetic Counselor Services Act Pursuing additional cosponasors and hearing for Cancer Drug Parity Act of 2019 (S.741/H.R.1730) Pursuing support for CLINICAL TREATMENT Act (H.R.913)

FY18 and FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.

FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.

FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.

FY19 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017. Supporting the re-authorization of Johanna's Law.

FY17 and FY18 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017.

FY17 and FY18 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017.

FY17 and FY18 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017.

FY17 and FY18 Appropriations for NIH, CDC, and DoD ovarian cancer programs. Supporting H.R.1409 - Cancer Drug Parity Act of 2017.

Appropriations for National Cancer Institute; CDC Ovarian Cancer Programs; Congressionally Directed Medical Research Program for Ovarian Cancer; 21st Century Cures; Regulation of Laboratory Developed Tests; Preserving Employee Wellness Program Act (S. 620/H.R.1189).

Appropriations for NCI, CDC Ovarian Cancer Programs, OCRP at CDMRP, Regulations for Laboratory Developed Tests, passage of Cancer Drug Parity Act HR 2739/S 1566.

Appropriations for NCI, CDC Ovarian Cancer Programs, OCRP at CDMRP, Regulations for Laboratory Developed Tests, passage of Cancer Drug Parity Act HR 2739/S 1566.

Appropriations for NCI, CDC Ovarian Cancer Programs, OCRP at CDMRP, Regulations for Laboratory Developed Tests, passage of Cancer Drug Parity Act HR 2739/S 1566.

Appropriations for NCI, CDC Ovarian Cancer Programs, OCRP at CDMRP, Regulations for Laboratory Developed Tests, passage of Cancer Drug Parity Act HR 2739/S 1566.

Appropriations for NCI, CDC Ovarian Cancer Programs, OCRP at CDMRP, Regulations for Laboratory Developed Tests, passage of Cancer Drug Parity Act HR 2739/S 1566.

Appropriations for NCI, CDC Ovarian Cancer Programs, OCRP at CDMRP, Regulations for Laboratory Developed Tests, passage of Cancer Drug Parity Act HR 2739/S 1566.

Appropriations for NCI, CDC Ovarian Cancer Programs, OCRP at CDMRP, Regulations for Laboratory Developed Tests, passage of Cancer Drug Parity Act HR 2739/S 1566.

Appropriations for NCI, CDC Ovarian Cancer Programs, OCRP at CDMRP, Regulations for Laboratory Developed Tests, passage of Cancer Drug Parity Act HR 2739/S 1566.

Appropriations for National Cancer Institute; CDC Ovarian Cancer Programs; Congressionally Directed Medical Research Program for Ovarian Cancer; 21st Century Cures; Regulation of Laboratory Developed Tests; Preserving Employee Wellness Program Act (S. 620/H.R.1189).